Xiangbei Welman Pharmaceutical Co. Ltd.

Xiangbei Welman is a leading Chinese pharmaceutical company specializing in R&D, manufacturing and sales of APIs and FDFs, and a leading enterprise in fixed-dose antibiotic combination products. Welman operates 10 GMP-compliant production lines including penicillin/cephalosporin powder for injection, sterile eye drops and nasal sprays, tablets, hard capsules, dry mixed suspension, granules and oral solid dosage forms, with main products including Piperacillin Sodium and Tazobactam Sodium (8:1), Tazobactam Sodium, Tadalafil, Ceftazidime and Avibactam Sodium for injection, and Amoxicillin and Clavulanate Potassium Tablets.